Drug Interaction Report

Desipramine and Clonidine Transdermal Patch: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Desipramine

Norpramin
+

Clonidine Transdermal Patch

Catapres Catapres-TTS®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 114 documented Desipramine interactions, 103 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
delayed
Evidence
probable
Severity
Major

What happens

Reduced antihypertensive effects and may counteract the hypotensive effects of cloNIDine

Interaction Deep Dive

Concomitant use of cloNIDine with desipramine (tricyclic antidepressant) can increase blood pressure and may counteract the hypotensive effects of cloNIDine21. Monitor blood pressure and adjust dosage of cloNIDine as needed 1. Tricyclic antidepressants increase the release of noradrenaline, presumably through re-uptake blockade. CloNIDine reduces the release of noradrenaline by stimulating pre-synaptic alpha-2 adrenoreceptors, whose function is to inhibit noradrenaline release 34. Mianserin, a tetracyclic antidepressant, was not shown to exhibit the impairment of cloNIDine's antihypertensive effects seen with tricyclic antidepressants 6.

Why it happens (mechanism)

Pharmacological antagonism at central alpha-2 receptors; unknown

Literature reports

4 reports — tap to read

a) The interaction between cloNIDine and desipramine was studied in five hypertensive patients. The results of this double-blind placebo controlled study showed that the introduction of the tricyclic antidepressant led to the loss of blood pressure control in four of the five subjects within two weeks. The rise in the arterial pressure was more prominent in the supine position than in the erect. The average blood pressure increase in the desipramine period compared to the placebo period was 22/15 mm Hg in the lying position and 12/11 mm Hg standing 3.

b) Eleven drug-free patients who met the Research Diagnostic Criteria for Major Depressive Disorder enrolled in a study to determine the effects of desipramine on central adrenergic function. Patients were given a cloNIDine infusion after 0, 1 and 3 weeks of treatment with desipramine. Results showed that the sedative and hypotensive effects of cloNIDine were significantly inhibited after three weeks of treatment with desipramine. This interaction was also seen at one week, but did not reach clinical significance. The authors concluded that the effects that were observed during the study were due to an acute drug effect, rather than to a chronic adaptive change 4.

c) One case report describes a 65-year-old man who was experiencing perineal pain following the excision of a carcinoma. Pain management of amitriptyline 75 mg nightly and sodium valproate 500 mg three times daily was initiated after slow-release morphine only had a limited effect. A cloNIDine spinal intrathecal injection of 75 micrograms was given when it was felt that the patient had become tolerant to opioid treatment. Within five minutes, the patient was found to be in severe pain, which resolved within 30 minutes after diamorphine was given. Two mechanisms for this interaction were postulated. In the first, the pain could have been the result of a cloNIDine-cholinergic interaction. In the second, the tricyclic augmentation of serotoninergic transmission may have unmasked an effect of cloNIDine at central receptors to enhance nociception 5.

d) Mianserin, a tetracyclic antidepressant, was not shown to exhibit the impairment of cloNIDine's antihypertensive effects seen with tricyclic antidepressants 67.

Common questions

Can I take Desipramine and Clonidine Transdermal Patch together?

Reduced antihypertensive effects and may counteract the hypotensive effects of cloNIDine Always confirm with your pharmacist or prescriber before making any change.

How serious is the Desipramine and Clonidine Transdermal Patch interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Desipramine or Clonidine Transdermal Patch need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (7)

  1. Product Information: ONYDA(TM) XR extended release suspension, clonidine hydrochloride extended release suspension. Tris Pharma, Inc (Per FDA), Monmouth Junction, NJ, 2024.
  2. Product Information: Catapres-TTS(R) transdermal system, clonidine transdermal system. Boehringer Ingelheim Pharmaceuticals, Inc. (per Manufacturer), Ridgefield, CT, 2012. DailyMed
  3. Briant RH, Reid JL, & Dollery CT: Interaction between clonidine and desipramine in man. Br Med J 1973; 1:522-523. PubMed
  4. Glass IB, Checkley SA, Shur E, et al: The effect of desipramine upon central adrenergic function in depressed patients. Br J Psychiatry 1982; 141:372-376. DOI
  5. Hardy PAJ & Wells JCD: Pain after spinal intrathecal clonidine. Anaesthesia 1988; 43:1026-1027. DOI
  6. Elliott HL, McLean K, Sumner DJ, et al: Pharmacodynamic studies on mianserin and its interaction with clonidine. Eur J Clin Pharmacol 1981; 21:97-102. PubMed
  7. Elliott HL, McLean K, Sumner DJ, et al: Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients. Eur J Clin Pharmacol 1983; 24:15-19. DOI
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.